Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer. [electronic resource]
- BMC cancer 07 2016
- 430 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1471-2407
10.1186/s12885-016-2423-x doi
Adult Aged Breast Neoplasms--drug therapy Chemotherapy, Adjuvant Female Humans Middle Aged Neoplasm Metastasis Neoplasm Recurrence, Local--epidemiology Receptors, Estrogen--metabolism Risk Factors Survival Analysis Tamoxifen--therapeutic use Young Adult